All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Promethera Biosciences SA, of Mont-Saint-Guibert, Belgium, raised €10 million (US$11 million) in a series C extension that included major existing shareholders Vesalius Biocapital, SRIW, Fund+, MGI Global Fund (Mitsui & Co.), Boehringer Ingelheim Venture Fund and SMS Investments.